News
Category
-
GlobeNewswire
Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies
March 31, 2020 -
GlobeNewswire
Arvelle Announces European Medicines Agency Acceptance of the Marketing Authorization Application (MAA) for Cenobamate
March 30, 2020 -
Business Wire
Compass Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy and Safety of CTX-471, a Unique Fully Human Agonist of CD137
March 30, 2020 -
GlobeNewswire
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
March 25, 2020 -
PR Newswire
AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available From BenchSci to Accelerate R&D Efforts
March 24, 2020 -
GlobeNewswire
Menlo Therapeutics Appoints Andrew Saik as Chief Financial Officer
March 24, 2020 -
GlobeNewswire
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
March 18, 2020 -
GlobeNewswire
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617
March 17, 2020 -
PR Newswire
Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy
March 17, 2020 -
GlobeNewswire
Hua Medicine Announces 2019 Annual Results
March 16, 2020 -
GlobeNewswire
GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
March 16, 2020 -
PR Newswire
Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis
March 16, 2020 -
PR Newswire
Buoy Health Calms Coronavirus Fear, Serves Up Population Health Data to Help Control the Rising Epidemic in the United States
March 16, 2020 -
GlobeNewswire
Beam Therapeutics Announces Key R&D Appointments
March 16, 2020 -
GlobeNewswire
Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation
March 12, 2020 -
GlobeNewswire
Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano
March 11, 2020 -
PR Newswire
TraceLink Achieves ISO 27017:2015 Security Certification
March 11, 2020 -
PR Newswire
TraceLink’s Continued Momentum Fuels Strong Company Growth and Investments in Q4 2019
March 10, 2020 -
Business Wire
Devoted Health recognized by Forbes as one of America’s Best Startup Employers in 2020
March 10, 2020 -
PR Newswire
Protenus Named One of Forbes’ Best Startup Employers of 2020
March 10, 2020 -
FierceBiotech
FierceMedTech names Insilico Medicine as one of its ‘Fierce 15’ companies of 2019
March 9, 2020 -
PR Newswire
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
March 9, 2020 -
PR Newswire
PatientPing Launches Educational Website Dedicated to CMS’s Interoperability and Patient Access Rule
March 9, 2020 -
GlobeNewswire
SIGA Announces Collaboration with Turnstone Biologics
March 3, 2020 -
PR Newswire
TraceLink Launches Global Corporate Social Responsibility Program, Focusing on Community Service and Philanthropic Contributions to Healthcare and STEM Organizations
March 3, 2020 -
Business Wire
IAA and Snapsheet Announce Partnership to Automate the Total Loss Process and Reduce Claims Cycle Time
March 3, 2020 -
PR Newswire
Innovent Biologics Announces First Patient Dosed in the Pivotal Registrational Trial of Pemigatinib in Patients with Advanced Cholangiocarcinoma in China
March 3, 2020 -
Newswire
Artemis Health and Quantros Partner to Provide a Holistic View of Healthcare Provider Quality
March 2, 2020 -
GlobeNewswire
Acacia Pharma Announces Changes to its Officers and Board of Directors
March 2, 2020 -
FierceBiotech
Akrevia no more, Xilio Therapeutics bags $101M for I-O programs
March 2, 2020 -
GlobeNewswire
TradeBlock and Grayscale Investments Partner to Publish TradeBlock Grayscale Digital Large Cap Index (DLCX)
February 27, 2020 -
FierceBiotech
Insilico Medicine taps GSK alum for a 6-month AI sprint aimed at brain cancer
February 27, 2020 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)
February 27, 2020 -
PR Newswire
Novaerus Donates Air Dis-infection Technology to Wuhan
February 27, 2020 -
GlobeNewswire
Acacia Pharma Announces US FDA Approval of BARHEMSYS® (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting (PONV)
February 27, 2020 -
Business Wire
Threat Stack Wins Cloud Security Category in Annual InfoSec Awards at RSA Conference 2020
February 25, 2020 -
Business Wire
Wellframe Announces Collaboration with Blue Cross and Blue Shield of Kansas City to Deliver Digital Health Management Solution to Members
February 24, 2020 -
Business Wire
Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
February 19, 2020 -
GlobeNewswire
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
February 18, 2020 -
PR Newswire
Breached Patient Records Tripled in 2019 as Malicious Actors Create New Problems for Patients
February 18, 2020 -
Business Wire
Nebula Genomics, Partnering with BGI, Sets Industry Standard by Offering 30x Whole-Genome Sequencing for $299
February 18, 2020 -
TechCrunch
Boston’s year jump starts as two local startups raise $520M in two rounds
February 17, 2020 -
GlobeNewswire
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer
February 13, 2020 -
Bloomberg
Flywire Becomes a Unicorn With New Investment From Goldman
February 13, 2020 -
PR Newswire
Avidity Biosciences Appoints Joseph Baroldi as Chief Operating Officer
February 12, 2020 -
Business Wire
Atrius Health Engages Kyruus to Advance Novel Digital Patient Access Initiatives
February 12, 2020 -
TechCrunch
MoEngage lands $25M for its mobile-first customer engagement platform
February 11, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Presentation of Clinical Data from Neurometabolic Franchise at 16th Annual WORLD Symposium
February 10, 2020 -
PR Newswire
Iora Health Closes $126 Million Series F Funding Round
February 10, 2020 -
Xconomy
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered
February 6, 2020 -
Fortune
Startup uses A.I. to identify molecules that could fight coronavirus
February 6, 2020 -
PR Newswire
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
February 6, 2020 -
F-Prime Capital
State of Venture, Technology
February 5, 2020 -
GlobeNewswire
Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Psoriasis in the Journal of the American Academy of Dermatology
February 5, 2020 -
Endpoints News
F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B
February 4, 2020 -
PR Newswire
Atrius Health And Firefly Health Announce Value-Based Care Affiliation
February 4, 2020 -
PR Newswire
PatientPing’s National Network of Next Generation ACO Providers Earns Over $150 Million in Savings for 2018
February 3, 2020 -
PR Newswire
2020 Best in KLAS Report Ranks Protenus No. 1 in Patient Privacy Monitoring
January 31, 2020 -
PR Web
Vitalware Achieves #1 in KLAS Revenue Cycle, Chargemaster Management Category for the Second Year in a Row
January 31, 2020 -
GlobeNewswire
Tempest Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPST-1495 and Welcomes New Investors
January 30, 2020 -
GlobeNewswire
Unum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor Cancers
January 29, 2020 -
GlobeNewswire
Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD)
January 29, 2020 -
FierceHealthcare
Blue Cross NC, Quartet roll out value-based payment model for mental health
January 28, 2020 -
PR Newswire
Revenue Insight emerges as world’s leading business intelligence solution for hospitality industry
January 28, 2020 -
PR Newswire
PatientPing Adds CommonWell Health Alliance’s Executive Director to Lead Strategic Partnership Initiatives
January 28, 2020 -
GlobeNewswire
Denali Therapeutics Announces Proposed Offering of Common Stock
January 27, 2020 -
Nasdaq
Gene editing biotech Beam Therapeutics sets terms for $100 million IPO
January 27, 2020 -
GlobeNewswire
Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiate Phase 1 Clinical Trials
January 27, 2020 -
PR Newswire
Benchling Unifies Hardware with Software to Maximize Lab Automation Investments
January 27, 2020 -
Xconomy
Beam Therapeutics Promotes Giuseppe Ciaramella to President
January 24, 2020 -
PR Newswire
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
January 21, 2020 -
PR Newswire
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT™ (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST
January 17, 2020 -
TechCrunch
Funnel closes $47M Series B to prepare marketing data for better reporting and analysis
January 17, 2020 -
GlobeNewswire
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2020 -
GlobeNewswire
GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome
January 15, 2020 -
Business Wire
Devoted Health Recognized in Built In Boston’s Best Places to Work List in 2020
January 15, 2020 -
TechCrunch
Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe
January 15, 2020 -
Xconomy
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
January 14, 2020 -
GlobeNewswire
Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinson’s Disease
January 14, 2020 -
Fierce Biotech
Astellas teams with Adaptimmune to create CAR-T, TCR therapies
January 14, 2020 -
GlobeNewswire
Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance
January 13, 2020 -
GlobeNewswire
Orchard Therapeutics Highlights 2020 Strategic Priorities
January 13, 2020 -
GlobeNewswire
Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States
January 13, 2020 -
Lumere
Global Healthcare Exchange Announces Acquisition of Lumere
January 13, 2020 -
GlobeNewswire
Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications
January 13, 2020 -
GlobeNewswire
Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma
January 13, 2020 -
GlobeNewswire
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
January 13, 2020 -
PR Newswire
Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada
January 13, 2020 -
Fierce Biotech
Ivenix taps new CEO as it brings its digital infusion pump to market
January 13, 2020 -
PR Newswire
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC
January 12, 2020